Clostridium Difficile

Infectious Disease·MeSH: Clostridium Infections

9 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
ibezapolstat (formerly ACX-362E)	Acurx Pharmaceuticals, Inc. (ACXP)
Vancomycin	Summit Therapeutics Inc. (SMMT)
ve303	IGM Biosciences, Inc. (IGMS)
VE303	IDEAYA Biosciences, Inc. (IDYA)

Phase 2(4)

Drug	Company
Fidaxomicin	Summit Therapeutics Inc. (SMMT)
ibezapolstat	Acurx Pharmaceuticals, Inc. (ACXP)
Ridinilazole	Summit Therapeutics Inc. (SMMT)
SMT19969	Summit Therapeutics Inc. (SMMT)

Phase 4(1)

Drug	Company
teicoplanin	Sanofi (SNY)

BioSniper tracks 9 drugs in development for Clostridium Difficile across 5 companies.

There are 1 clinical trial targeting Clostridium Difficile tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.